Dropping with the temps: Cool deals on CST mAbs | Learn More >>
Activators & Inhibitors

Gefitinib #4765

Western Blotting

Western blot analysis of extracts from BxPC-3 cells, untreated or treated with EGF (100 ng/ml, 5 min) either with or without gefinitib pre-treatment (10 µM, 2 hr), using Phospho-EGF Receptor (Tyr1173) (53A5) Rabbit mAb #4407 (upper) or EGF Receptor Antibody #2232 (lower).

Learn more about how we get our images

Chemical structure of gefitinib.

Learn more about how we get our images

Gefinitib is supplied as a lyophilized powder. For a 10 mM stock, reconstitute the 10 mg in 2.24 ml DMSO. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used as a pretreatment at 0.1-10 µM for 0.5-2 hr prior to treating with a stimulator. It can also be used alone, with varying treatment times lasting up to 24 hr. Soluble in DMSO at 100 mg/ml; very poorly soluble in ethanol and water.


Store lyophilized or in solution at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Molecular Weight:

446.90 g/mol



Molecular Formula:


Gefitinib is a novel and potent EGFR tyrosine kinase inhibitor that binds to the ATP-binding site of the enzyme, and has been shown to be competitive with ATP and noncompetitive with peptide substrates (1). Gefitinib inhibits in vitro EGFR activity (IC50 = 33 nM), significantly inhibits EGF-stimulated tumor cell growth (IC50 = 54 nM) when compared to the absence of EGF (IC50 = 8.8 µM), and effectively blocks EGF-stimulated autophosphorylation in tumor cells. It also selectively inhibits EGF-stimulated growth of HUVE cells compared with FGF- or VEGF-stimulated growth (1). Although studies demonstrate gefitinib to be much more selective for EGFR than HER2 (1,2), it has also shown to inhibit growth and phosphorylation of HER2 in numerous HER2-overexpressing cell lines (3).

  1. Wakeling, A.E. et al. (2002) Cancer Res 62, 5749-54.
  2. Wood, E.R. et al. (2004) Cancer Res 64, 6652-9.
  3. Moasser, M.M. et al. (2001) Cancer Res 61, 7184-8.
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.


To Purchase # 4765S

View sizes
Product # Size Price
10 mg $ 137.0